HomeBUSINESS
BUSINESS

Mogamulizumab Accepted for Review in Europe: Kyowa Kirin
(Oct.30.2017)

Kyowa Hakko Kirin said on October 27 that its marketing authorization application filed in Europe for mogamulizumab for the treatment of cutaneous T-cell lymphoma (CTCL) was accepted for review by the European Medicines Agency (EMA) ...
(LOG IN FOR FULL STORY)

News Calendar